- AdventHealth Research Institute
AdventHealth Neuroscience Institute is launching THRIVE, a new NIH-funded clinical trial led by geriatric neuropsychologist and neuroscience researcher Lauren Oberlin, PhD. The study will test whether digital cognitive training — a series of computer-based brain exercises — can improve mood, cognitive function, and brain network connectivity in older adults experiencing apathy and depression.
Apathy, a motivational disturbance that impacts up to 50% of people with late-life depression, often leads to social withdrawal, poor self-care, and increased disability. Current treatments like antidepressants may not address apathy and, in some cases, can worsen it. THRIVE aims to fill this gap with a non-invasive, home-based intervention that involves 25–30 minutes of engaging brain training five days a week for four weeks.
Participants will complete mood and cognitive assessments, as well as brain imaging, to help researchers understand how digital training may re-engage critical brain networks. “We are excited about this trial as it has the potential to identify a novel intervention that can be used alongside current treatments to improve outcomes for older adults,” says Dr. Oberlin.
Learn more about this study by clicking below.
Recent News
Advancing Cancer Research Closer to Home
At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...
AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions
AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members...
Moving More, Managing Better
For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.
New study to examine pairing GLP-1 medication with exercise to reduce Alzheimer’s disease risk
AdventHealth researcher awarded state grant to explore a new prevention approach aimed at protecting memory, independence and quality of life.
The Lessons We Never Expected From Type 1 Diabetes
When a child is diagnosed with Type 1 Diabetes (T1D), families quickly realize they’re learning much more than carb counting and insulin dosing. They’re learning resilience, advocacy, patience, and...
The Power of Participation
Before new diabetes technologies reach patients… before new treatments improve daily life… before researchers better understand diseases like Type 1 diabetes (T1D)… someone has to volunteer for the...
Bringing Cancer Research Into the Home: Dr. Justin Brown's Approach to Trial Design
Justin Brown, PhD, Associate Investigator at AdventHealth, has dedicated his career to studying how exercise can improve outcomes for cancer patients after losing his father to colon cancer as a...
Exercise as “Powerful Medicine”: Spotlight on AdventHealth Research
Recently, Dr. Bret Goodpaster, scientific director of the AdventHealth Translational Research Institute (TRI), appeared on FOX 35 News to discuss groundbreaking research exploring how exercise impacts...
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...